I think AI could be used nefariously and will be by state actors to influence domestic issues.

I think that we could do that easily.

Fair to say we are on the cusp of all the potential that might be good ahead of us, but a lot of the potential issues, which would beg the kind of a general regulatory framework, are just coming to the surface.

I think AI could be used nefariously and will be by state actors to influence domestic issues.

We have got to be careful about that.

I think that we could do that easily.

Mr. President, I rise today to recognize Eddie Hughes on 60 years of service at UPS. Eddie Hughes was born in Mt. Pleasant, MS, and moved to Indianapolis to take a job with UPS in 1963. His only hiatus came from 1965-1966, when Eddie…

Thank you, Mr. Chairman. My pleasure to introduce Dr. Peggy Plews-Ogan.

Mr. President, I call up my amendment No. 1182 and ask that it be reported by number. The PRESIDING OFFICER. The clerk will report. The senior assistant legislative clerk read as follows: The Senator from Indiana [Mr. Braun], for himself…

Mr. President, Americans are hurting more than I think in any other time since I have been here for sure: high inflation--I calculate in the 5 years I have been here, we have added 15 trillion to our national debt--struggling to make ends…

First of all, I echo the comments of Senators Collins and Murray on the tragedy in Maine. We see it all too often. When it comes to this place, we don't do budgets anymore. We haven't done them--that we have adhered to--in over 20 years…

And I ask for the yeas and nays. The PRESIDING OFFICER. The question is on agreeing to the amendment. Is there a sufficient second? There appears to be a sufficient second. The clerk will call the roll. The senior assistant legislative…

Thank you, Mr. Chairman. My pleasure to introduce Dr. Peggy Plews-Ogan.

That is why we need the formality of PPA.

We should be that leading edge and we should have a system that accommodates it.

However, millions of Americans with these diseases still lack any FDA approved treatments.

I have been working on this for most of the five-years I have been here in the Senate.

My simple answer is that ALS patients are willing to accept greater risk because we know what is behind door number two.